[1] |
Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64(1): 73-84.
doi: 10.1002/hep.28431
pmid: 26707365
|
[2] |
Younossi ZM, Otgonsuren M, Henry L, et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009[J]. Hepatology, 2015, 62(6): 1723-1730.
doi: 10.1002/hep.28123
pmid: 26274335
|
[3] |
Holt SC, Ebersole JL. Porphyromonas gingivalis, treponema denticola, and tannerella forsythia: the“red complex”, a prototype polybacterial pathogenic consortium in periodontitis[J]. Periodontol, 2005, 38: 72-122.
doi: 10.1111/prd.2005.38.issue-1
URL
|
[4] |
Furuta M, Ekuni D, Yamamoto T, et al. Relationship between periodontitis and hepatic abnormalities in young adults[J]. Acta Odontologica Scandinavica, 2010, 68(1): 27-33.
doi: 10.3109/00016350903291913
pmid: 19878045
|
[5] |
Kim JY, Lee GN, Song HC, et al. Association between fatty liver index and periodontitis: the Korea National Health and Nutrition Examination Survey[J]. Sci Rep, 2020, 10(1): 3805.
doi: 10.1038/s41598-020-60797-7
|
[6] |
Kuroe K, Furuta M, Takeuchi K, et al. Association between periodontitis and fibrotic progression of non-alcoholic fatty liver among Japanese adults[J]. J Clin Periodontol, 2021, 48(3): 368-377.
doi: 10.1111/jcpe.13415
pmid: 33368494
|
[7] |
Akinkugbe AA, Slade GD, Barritt AS, et al. Periodontitis and non-alcoholic fatty liver disease, a population-based cohort investigation in the Study of Health in Pomerania[J]. J Clin Periodontol, 2017, 44(11): 1077-1087.
doi: 10.1111/jcpe.12800
pmid: 28804947
|
[8] |
杜芹, 马歆茹. 牙周致病菌与系统性疾病的相关性研究进展[J]. 南方医科大学学报, 2020, 40(5): 759-764.
|
[9] |
Yoneda M, Naka S, Nakano K, et al. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease[J]. BMC Gastroenterol, 2012, 12: 16.
doi: 10.1186/1471-230X-12-16
URL
|
[10] |
Nakahara T, Hyogo H, Ono A, et al. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease[J]. J Gastroenterol, 2018, 53(2): 269-280.
doi: 10.1007/s00535-017-1368-4
pmid: 28741270
|
[11] |
Furusho H, Miyauchi M, Hyogo H, et al. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice[J]. J Gastroenterol, 2013, 48(11): 1259-1270.
doi: 10.1007/s00535-012-0738-1
pmid: 23307045
|
[12] |
Kuraji R, Ito H, Fujita M, et al. Porphyromonas gingivalis induced periodontitis exacerbates progression of non-alcoholic steatohepatitis in rats[J]. Clin Exp Dent Res, 2016, 2(3): 216-225.
doi: 10.1002/cre2.v2.3
URL
|
[13] |
杜留熠, 孙晓琳, 于维先, 等. 牙龈卟啉单胞菌菌毛致病机制的研究进展[J]. 中华口腔医学杂志, 2018, 53(10): 703-707.
|
[14] |
Nakano K, Inaba H, Nomura R, et al. Distribution of Porphyromonas gingivalis fimA genotypes in cardiovascular specimens from Japanese patients[J]. Oral Microbiol Immunol, 2008, 23(2): 170-172.
doi: 10.1111/omi.2008.23.issue-2
URL
|
[15] |
Arimatsu K, Yamada H, Miyazawa H, et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota[J]. Sci Rep, 2014, 4: 4828.
doi: 10.1038/srep04828
pmid: 24797416
|
[16] |
Nakajima M, Arimatsu K, Kato T, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver[J]. PLoS One, 2015, 10(7): e0134234.
doi: 10.1371/journal.pone.0134234
URL
|
[17] |
Yamazaki K, Kato T, Tsuboi Y, et al. Oral pathobiont-induced changes in gut microbiota aggravate the pathology of nonalcoholic fatty liver disease in mice[J]. Front Immunol, 2021, 12: 766170.
doi: 10.3389/fimmu.2021.766170
URL
|
[18] |
Armingohar Z, Jørgensen JJ, Kristoffersen AK, et al. Bacteria and bacterial DNA in atherosclerotic plaque and aneurysmal wall biopsies from patients with and without periodontitis[J]. J Oral Microbiol, 2014, 6(1): 3402.
|
[19] |
Geerts SO, Nys M, De MP, et al. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity[J]. J Periodontol, 2002, 73(1): 73-78.
doi: 10.1902/jop.2002.73.1.73
pmid: 11846202
|
[20] |
Wahaidi VY, Kowolik MJ, Eckert GJ, et al. Endotoxemia and the host systemic response during experimental gingivitis[J]. J Clin Periodontol, 2011, 38(5): 412-417.
doi: 10.1111/j.1600-051X.2011.01710.x
pmid: 21320151
|
[21] |
Sasaki N, Katagiri S, Komazaki R, et al. Endotoxemia by porphyromonas gingivalis injection aggravates non-alcoholic fatty liver disease, disrupts glucose/lipid metabolism, and alters gut microbiota in mice[J]. Front Microbiol, 2018, 9: 2470.
doi: 10.3389/fmicb.2018.02470
pmid: 30405551
|
[22] |
张冬霞, 林江. 中性粒细胞在牙周炎和糖尿病双向关系中作用的研究进展[J]. 医学综述, 2019, 25(17): 3338-3343.
|
[23] |
邹慧琼, 刘雅芳, 周家敏, 等. 牙周非手术治疗对慢性牙周炎患者循环CD34+/CD309+/CD45-内皮祖细胞和氧化三甲胺的影响[J]. 临床口腔医学杂志, 2022, 38(2): 82-86.
|
[24] |
Méndez-Sánchez N, Valencia-Rodríguez A, Coronel-Castillo C, et al. The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis[J]. Ann Transl Med, 2020, 8(6): 400.
doi: 10.21037/atm.2020.02.184
pmid: 32355844
|
[25] |
Yu S, Ding L, Liang D, et al. Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing α-ketoglutarate production in mice[J]. Mol Oral Microbiol, 2018, 33(5): 388-395.
doi: 10.1111/omi.12241
pmid: 30007055
|
[26] |
周玲. 牙龈卟啉单胞菌脂多糖对骨质疏松大鼠骨髓巨噬细胞生物学行为的影响[D]. 福州: 福建医科大学, 2019.
|
[27] |
Han YH, Kim HJ, Na H, et al. RORα induces KLF4-mediated M2 polarization in the liver macrophages that protect against nonalcoholic steatohepatitis[J]. Cell Reports, 2017, 20(1):124-135.
doi: 10.1016/j.celrep.2017.06.017
URL
|
[28] |
Neufeld-Cohen A, Robles MS, Aviram R, et al. Circadian control of oscillations in mitochondrial rate-limiting enzymes and nutrient utilization by PERIOD proteins[J]. Proc Natl Acad Sci U S A, 2016, 113(12): E1673-E1682.
|
[29] |
Gooley JJ. Circadian regulation of lipid metabolism[J]. Proc Nutr Soc, 2016, 75(4): 440-450.
pmid: 27225642
|